Sustained inhibition of HIV-1 replication by conditional expression of the E. coli-derived endoribonuclease MazF in CD4+ T cells

Human Gene Therapy Methods

Volumn 24, Issue 2, 2013, Pages 94-103

  Okamoto, Mika ^a   Chono, Hideto ^b   Kawano, Yasuhiro ^b   Saito, Naoki ^b   Tsuda, Hiroshi ^b   Inoue, Koichi ^b   Kato, Ikunoshin ^b   Mineno, Junichi ^b   Baba, Masanori ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b TAKARA BIO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PROTEIN MAZF; RIBONUCLEASE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL GROWTH; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOPLASM; ESCHERICHIA COLI; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS STRAIN;

CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; DNA-BINDING PROTEINS; DRUG RESISTANCE, MULTIPLE, VIRAL; ENDORIBONUCLEASES; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE ORDER; GENETIC VECTORS; HIV-1; HUMANS; INTRACELLULAR SPACE; LEUKOCYTES, MONONUCLEAR; MUTATION; PROTEIN TRANSPORT; RETROVIRIDAE; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; TRANSDUCTION, GENETIC; VIRAL TROPISM; VIRUS REPLICATION;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84878746384     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.131     Document Type: Article

References (28)

1. Baba, M., Miyake, H., Okamoto, M., et al. (2000). Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1. AIDS Res. Hum. Retroviruses 16, 935-941.
2. Baba, M., Miyake, H., Wang, X., et al. (2007). Isolation and characterization of human immunodeficiency virus type 1 resistant to the small-molecule CCR5 antagonist TAK-652. Antimicrob. Agents Chemother. 51, 707-715.
3. Chono, H., Matsumoto, K., Tsuda, H., et al. (2011a). Acquisition of HIV-1 resistance in T lymphocytes using an ACA-specific E. coli mRNA interference. Hum. Gene Ther. 22, 35-43.
4. Chono, H., Saito, N., Tsuda, H., et al. (2011b). In vivo safety and persistence of endoribonuclease gene-transduced CD4+ T cells in cynomolgus macaques for HIV-1 gene therapy model. PLoS One 6, e23585.
5. Coiras, M., López-Huertas, M.R., Pérez-Olmeda, M., and Alcamí, J. (2009). Understanding HIV-1 latency provides clues for the eradication of long-term resevoirs. Nat. Rev. Microbiol. 7, 798-812.
6. Dropulić, B., and Jeang, K.T. (1994). Gene therapy for human immunodeficiency virus infection: genetic antiviral strategies and targets for intervention. Hum. Gene Ther. 5, 927-939.
7. Harada, S., Koyanagi, Y., and Yamamoto, N. (1985). Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay. Science 229, 563-566.
8. Harrison, G.P., and Lever, A.M. (1992). The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J. Virol. 66, 4144-4153.
9. Hirsch, M.S., Günthard, H.F., Schapiro, J.M., et al. (2008). Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendation of an International AIDS Society-USA panel. Top. HIV Med. 16, 266-285.
10. Karn, J. (1999). Tackling Tat. J. Mol. Biol. 293, 235-254.
11. Lee, J.T., Yu, S.S., Han, E., et al. (2004). Engineering the splice acceptor for improved gene expression and viral titer in an MLV-based retroviral vector. Gene Ther. 11, 94-99.
12. Lee, N.S., and Rossi, J.J. (2004). Control of HIV-1 replication by RNA interference. Virus Res. 102, 53-58.
13. Li, M.J., Kim, J., Li, S., et al. (2005). Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy. Mol. Ther. 12, 900-909.
14. Levine, B.L., Humeau, L.M., Boyer, J., et al. (2006). Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 103, 17372-17377.
15. Morris, K.V., and Rossi, J.J. (2006). Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection. Hum. Gene. Ther. 17, 479-486.
16. Nitanda, T., Wang, X., Kumamoto, H., et al. (2005). Anti-human immunodeficiency virus type 1 activity and resistant profile of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine in vitro. Antimicrob. Agents Chemother. 49, 3355-3360.
17. Pauwels, R., Balzarini, J., Baba, M., et al. (1988). Rapid and sutomated tetrazolium-dased colorimetric assay for the detection of anti-HIV compounds. J. Virol. Methods 20, 309-321.
18. Pomerantz, R.J., and Horn, D.L. (2003). Twenty years of therapy for HIV-1 infection. Nat. Med. 9, 867-873.
19. Reed, L.J., and Muench, H. (1938). A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493-497.
20. Rossi, J.J., June, C.H., and Kohn, D.M. (2007). Genetic therapies against HIV. Nat. Biotechnol. 25, 1444-1454.
21. Sarver, N., and Rossi, J. (1993). Gene therapy: a bold direction for HIV-1 treatment. AIDS Res. Hum. Retroviruses 9, 483-487.
22. Shibuyama, S., Gevorkyan, A., Yoo, U., et al. (2006). Understanding and avoiding antiretroviral adverse events. Curr. Pharm. Dis. 12, 1075-1090.
23. Shimazu, T., Degenhardt, K., Nur-E-Kamal, A., et al. (2007). NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition. Genes Dev. 21, 929-941.
24. St. Louis, D.C., Gotte, D., Sanders-Buell, E., et al. (1998). Infectious molecular clones with the nonhomologous dimmer initiation sequence found in different subtypes of human immunodeficiency virus type 1 can recombine and initiate a spreading infection in vitro. J. Virol. 72, 3991-3998.
25. Thompson, M.A., Aberg, J.A., Cahn, P., et al. (2010). Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 304, 321-333.
26. van Lunzen, J., Glaunsinger, T., Stahmer, I., et al. (2007). Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus. Mol. Ther. 15, 1024-1033.
27. Verzeletti, S., Bonini, C., Marktel, S., et al. (1998). Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. Hum. Gene Ther. 9, 2243-2251.
28. Weiss, R.A. (2008). Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges. Clin. Exp. Immunol. 152, 201-210.